# NKG2D CAR-NK & Ovarian Cancer

> **NCT05776355** · NA · UNKNOWN · sponsor: **Hangzhou Cheetah Cell Therapeutics Co., Ltd** · enrollment: 18 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** NKG2D CAR-NK

## Key facts

- **NCT ID:** NCT05776355
- **Lead sponsor:** Hangzhou Cheetah Cell Therapeutics Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03
- **Primary completion:** 2024-04
- **Final completion:** 2024-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05776355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05776355, "NKG2D CAR-NK & Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05776355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*